{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:24:42Z","timestamp":1789680282946,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100020180","name":"Japanese Society of Allergology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.resinv.2024.12.010","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T23:52:41Z","timestamp":1734393161000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessing the utility of fractional exhaled nitric oxide-guided management in adult patients with asthma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-9329","authenticated-orcid":false,"given":"Hiroaki","family":"Tsurumaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7911-8102","authenticated-orcid":false,"given":"Yuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-0450","authenticated-orcid":false,"given":"Keiji","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3231-7841","authenticated-orcid":false,"given":"Tadao","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-5378","authenticated-orcid":false,"given":"Tomoko","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.12.010_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0042-1743290","article-title":"FeNO in asthma","volume":"43","author":"Loewenthal","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","author":"American Thoracic","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/thoraxjnl-2016-208704","article-title":"Accuracy of FENO for diagnosing asthma: a systematic review","volume":"72","author":"Karrasch","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.12.010_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1164\/rccm.200411-1498OC","article-title":"Exhaled nitric oxide: a predictor of steroid response","volume":"172","author":"Smith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S2213-2600(17)30424-1","article-title":"Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.rmed.2018.08.005","article-title":"Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function","volume":"143","author":"Mansur","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/cea.13137","article-title":"Simultaneously elevated FeNO and blood eosinophils relate to asthma morbidity in asthmatics from NHANES 2007-12","volume":"48","author":"Mogensen","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2024.12.010_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.010_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2024.12.010_bib11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib12","first-page":"46","article-title":"Exhaled nitric oxide (FENO) levels to guide treatment for adults with asthma: a cochrane systematic review","volume":"2","author":"Petsky","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.12.010_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1183\/13993003.01882-2015","article-title":"Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review","volume":"47","author":"Essat","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.010_bib14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/cea.14359","article-title":"Effectiveness of FeNO-guided treatment in adult asthma patients: a systematic review and meta-analysis","volume":"53","author":"Korevaar","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2024.12.010_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.resinv.2024.12.010_bib16","series-title":"Minds manual for guideline development 2020 ver. 3.0","year":"2021"},{"key":"10.1016\/j.resinv.2024.12.010_bib17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2024.12.010_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2024.12.010_bib19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.010_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.12.010_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.rmed.2013.02.018","article-title":"Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates","volume":"107","author":"Donohue","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib22","series-title":"Review manager","year":"2020"},{"key":"10.1016\/j.resinv.2024.12.010_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2024.12.010_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/thx.2010.153411","article-title":"Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial","volume":"66","author":"Hashimoto","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.12.010_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.07.016","article-title":"Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care","volume":"135","author":"Honkoop","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2024.12.010_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(11)60971-9","article-title":"Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial","volume":"378","author":"Powell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2024.12.010_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.200610-1427OC","article-title":"The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial","volume":"176","author":"Shaw","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib28","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMoa043596","article-title":"Use of exhaled nitric oxide measurements to guide treatment in chronic asthma","volume":"352","author":"Smith","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaip.2013.07.013","article-title":"Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial","volume":"1","author":"Syk","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.resinv.2024.12.010_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00147-2017","article-title":"FeNo-based asthma management results in faster improvement of airway hyperresponsiveness","volume":"4","author":"Bernholm","year":"2018","journal-title":"ERJ Open Research"},{"issue":"1","key":"10.1016\/j.resinv.2024.12.010_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mjafi.2018.02.001","article-title":"Exhaled nitric oxide as a guiding tool for bronchial asthma: a randomised controlled trial","volume":"76","author":"Garg","year":"2020","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.resinv.2024.12.010_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.advms.2020.03.001","article-title":"The beneficial role of FeNO in association with GINA guidelines for titration of inhaled corticosteroids in adult asthma: a randomized study","volume":"65","author":"Truong-Thanh","year":"2020","journal-title":"Adv Med Sci"},{"issue":"1","key":"10.1016\/j.resinv.2024.12.010_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/med-2019-0015","article-title":"The reliability of adjusting stepped care based on FeNO monitoring for patients with chronic persistent asthma","volume":"14","author":"Wang","year":"2019","journal-title":"Open Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib35","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.2174\/1871524915666150710123415","article-title":"The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study","volume":"21","author":"Malerba","year":"2015","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.resinv.2024.12.010_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaip.2019.06.033","article-title":"How maternal BMI modifies the impact of personalized asthma management in pregnancy","volume":"8","author":"Murphy","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2024.12.010_bib37","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1183\/09031936.00118809","article-title":"Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma","volume":"35","author":"Perez-de-Llano","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.010_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/13993003.02150-2019","article-title":"Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.010_bib40","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.alit.2017.02.003","article-title":"Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma","volume":"66","author":"Nagasaki","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2024.12.010_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.12.010_bib43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.010_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.resinv.2020.05.006","article-title":"An official JRS statement: the principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice","volume":"59","author":"Matsunaga","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.12.010_bib45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2014.10.026","article-title":"Biomarker-based asthma phenotypes of corticosteroid response","volume":"135","author":"Cowan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2024.12.010_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12931-023-02437-y","article-title":"Economic impact of a more extensive use of FENO testing on the Italian population with asthma","volume":"24","author":"Rognoni","year":"2023","journal-title":"Respir Res"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:05:52Z","timestamp":1740146752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2212534524001977"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.12.010","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the utility of fractional exhaled nitric oxide-guided management in adult patients with asthma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}